Date: 2012-06-29
Type of information: Grant
Company: Mimetas (The Netherlands)
Investors: Dutch Foundation for Applied Sciences (STW) (The Netherlands)
Amount: € 200 000
Funding type: grant
Planned used: Researchers from the Leiden/Amsterdam Centre for Drug Research (LACDR) in Leiden have received 200.000 euros to develop their work on Organs on-a-Chip into marketable products. As part of this effort, the company Mimetas has been founded that will bring solutions for micro tissue- and organ culturing to the market.
Others: Mimetas is a Leiden-based microfluidics company focusing on high-throughput biomimetic 3D culture systems for predictive toxicology testing, efficacy screening and personalized therapy. Currently, Mimetas develops its products to help pharmaceutical companies make better medicines at lower costs. The company is the result of research and business development efforts by Paul Vulto, Thomas Hankemeier and Bas Trietsch from the University of Leiden and biotech-entrepreneur Jos Joore. Research has been performed within and with support of the Division of Analytical Biosciences and the Netherlands Metabolomics Centre.
Therapeutic area: Technology - Services
